Resurgent Financial Advisors LLC Becton Dickinson & CO Transaction History

Resurgent Financial Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$232.24 - $267.23 $158,155 - $181,983	-681 Reduced 52.91%	606 $147,000
Q3 2023 Nov 13, 2023	SELL	$254.9 - $283.59 $20,901 - $23,254	-82 Reduced 5.99%	1,287 $332,000
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $238 - $265	-1 Reduced 0.07%	1,369 $361,000
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $47,549 - $53,685	-207 Reduced 13.13%	1,370 $339,000
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $138,832 - $163,394	636 Added 67.59%	1,577 $401,000
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $459 - $2,378	-9 Reduced 0.95%	941 $210,000
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $29,107 - $34,152	124 Added 15.01%	950 $234,000
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $201,246 - $223,416	826 New	826 $220,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resurgent Financial Advisors LLC with notifications on news.